Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
3.640
-0.030 (-0.82%)
At close: Sep 16, 2026, 4:00 PM EDT
3.630
-0.010 (-0.27%)
After-hours: Sep 16, 2026, 4:35 PM EDT
Bicycle Therapeutics Employees
Bicycle Therapeutics had 288 employees as of December 31, 2025. The number of employees decreased by 17 or -5.57% compared to the previous year.
Employees
288
Change (1Y)
-17
Growth (1Y)
-5.57%
Revenue / Employee
$212,517
Profits / Employee
-$661,153
Market Cap
254.77M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 288 | -17 | -5.57% |
| Dec 31, 2024 | 305 | 21 | 7.39% |
| Dec 31, 2023 | 284 | 48 | 20.34% |
| Dec 31, 2022 | 236 | 117 | 98.32% |
| Dec 31, 2021 | 119 | 32 | 36.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Lyell Immunopharma | 161 |
| Fate Therapeutics | 161 |
| Sutro Biopharma | 128 |
| AC Immune | 122 |
| Invivyd | 122 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 57 |
BCYC News
- 6 weeks ago - Visa Inks $2.4 Billion Deal to Acquire Fraud Prevention Firm BioCatch - PYMNTS
- 6 weeks ago - Bicycle Therapeutics assumed with an Outperform at Oppenheimer - TheFly
- 6 weeks ago - Bicycle Therapeutics reports Q2 EPS (72c), consensus (58c) - TheFly
- 6 weeks ago - Bicycle Therapeutics sees cash runway into 2030 - TheFly
- 6 weeks ago - Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results - Business Wire
- 6 weeks ago - Bicycle Therapeutics Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Bicycle Therapeutics Earnings release: Q2 2026 - Filings
- 6 weeks ago - Bicycle Therapeutics Slides: Corporate presentation - Filings